4.2 Article

Phenotypic variability in patients with unique double homozygous mutations causing variant ataxia telangiectasia

期刊

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
卷 32, 期 -, 页码 36-39

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.ejpn.2021.03.008

关键词

Ataxia-telangiectasia; Variant; ATM; Homozygous; Neurodegenerative

向作者/读者索取更多资源

Variant A-T patients with the same mutations in ATM exhibit variable phenotypes, likely influenced by environmental, epigenetic, and post-translational factors. Early onset truncal ataxia and increased risk of childhood malignancy are common features in some patients.
Ataxia-Telangiectasia (A-T) is a neurodegenerative disease caused by bi-allelic mutations in the AtaxiaTelangiectasia-Mutated (ATM) gene. Complete lack of ATM activity leads to severe A-T and mutations allowing for residual activity cause a milder phenotype, termed variant A-T. There are only sparse data on the variability in phenotypes of variant A-T patients carrying the same mutations. A retrospective study of 15 patients with variant A-T, all double homozygous for the same mutations was conducted. The age of first symptom ranged from 4-180 months, including: truncal ataxia at <18 months of age in 9 patients, ataxia and instability only during fever in one patient, dystonia in one patient and malignancy in 4 patients. Global developmental delay and occulo-motor apraxia were recorded in 4/14 patients. Variant A-T patients with the same mutations in ATM, have variable phenotypes. Environmental, epigenetic, and post translational factors are likely to play a role in creation of the phenotype in variant A-T patients. (c) 2021 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Adrenal function following ACTH therapy for infantile spasms: A retrospective study

J. Bistritzer, I. Noyman, G. Hazan, E. Hershkovitz, A. Haim

CLINICAL NEUROLOGY AND NEUROSURGERY (2020)

Article Pediatrics

The effect of vitamin D administration on vitamin D status and respiratory morbidity in late premature infants

Inbal Golan-Tripto, Jacob Bistritzer, Neta Loewenthal, Orna Staretz-Chacham, Yotam Dizitzer, Aviv Goldbart

PEDIATRIC PULMONOLOGY (2020)

Article Clinical Neurology

Respiratory function in LAMA2-related muscular dystrophy and SELENON-related congenital myopathy, a 1.5-year natural history study

Karlijn Bouman, Jeroen L. M. van Doorn, Jan T. Groothuis, Peter J. Wijkstra, Baziel G. M. van Engelen, Corrie E. Erasmus, Jonne Doorduin, Nicol C. Voermans

Summary: The majority of LAMA2-MD and all SELENON-RM patients had respiratory impairment. SELENON-RM patients showed lower respiratory function which was progressive, more prevalent mechanical ventilation, and more severe diaphragm atrophy and dysfunction than LAMA2-MD patients. Spirometry (FVC%, dVC) and respiratory muscle strength tests (SNIP) are useful in clinical care and as outcome measure in clinical trials.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2024)

Article Clinical Neurology

An online survey among general pediatricians on melatonin use in children with chronic insomnia

Oliviero Bruni, Maria Breda, Emanuela Malorgio, Paolo Brambilla, Flavia Ceschin, Andrea Di Pilla, Maurizio Elia, Raffaele Ferri

Summary: This study aimed to describe the use of melatonin by Italian pediatricians in healthy children with chronic insomnia. The results showed that a high percentage of pediatricians prescribed melatonin, especially in children aged 1-2 years. The most common dosage was 1 mg/day and it was usually recommended to be taken 30 minutes before bedtime. Melatonin was often combined with sleep hygiene and was found to be effective in reducing difficulties falling asleep.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2024)

Article Clinical Neurology

Yield of exome sequencing in patients with developmental and epileptic encephalopathies and inconclusive targeted gene panel

Lucie Sedlackova, Katalin Sterbova, Marketa Vlckova, Pavel Seeman, Jana Zarubova, Petr Marusic, Pavel Krsek, Hana Krijtova, Alena Musilova, Petra Lassuthova

Summary: In this study, whole exome sequencing (WES) was performed to identify causal variants for developmental and epileptic encephalopathies (DEEs) in patients whose genetic diagnosis was not determined by gene panel testing. The results showed that WES can successfully identify disease-causing variants, even after inconclusive gene panel testing. Detailed clinical evaluations and phenotype-genotype correlation studies were conducted to better understand the rare subtypes of DEEs.

EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2024)